Skip to content

Effects of early LBBP resynchronization on cardiac function and synchrony in HF patients and LBBB with mild cardiac dysfunction

Effects of early LBBP resynchronization on cardiac function and synchrony in HF patients and LBBB with mild cardiac dysfunction

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070954
Enrollment
Unknown
Registered
2023-04-27
Start date
2021-12-04
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LBBB and HF with mild reduced LVEF

Interventions

LBBP group:N/A

Sponsors

Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Patients with typical left bundle branch block (LBBB). Definition of LBBB: Strauss definition criteria include QRS duration = 140 ms (male) = 130 ms (female), QRS dent or blur in two or more adjacent V1, V2, V3, V4, V5, V6, I and AVL leads, QS or RS in V1 and V2. 2) Patients with Heart failure symptom: Clinical symptoms of chest tightness and shortness of breath; Exclude others requiring coronary angioplasty; After more than 3 months of drug treatment; Cardiac ultrasound (LVEF) < between 50% (eg, baseline 60% < LVEF (ECHO) < 50%, and the gold standard LVEF (including short-axis LVEF and long-axis LVEF) < less than 50% can be enrolled by cardiac magnetic resonance. 3) Patients aged 18 and above. 4) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients who cannot participate in follow-up for reasons. 2) Active infection. 3) Women who are expected to become pregnant or breastfeeding within 1 year. 4) Participated in other clinical trials within the last 3 months. 5) Poor compliance, unable to strictly implement the scheme. 6) Vulnerable groups, including mental illness, cognitive impairment, critically ill patients, minors, pregnant women, students / subordinates of PI or researchers, employees of research units or sponsors, etc. 7) Any other circumstances that the investigator considers unsuitable for participation in the trial.

Design outcomes

Primary

MeasureTime frame
Cardiac echo;

Secondary

MeasureTime frame
MIBI-18PDG;

Countries

China

Contacts

Public ContactGuosheng Fu

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

fugs@zju.edu.cn+86-0571-86006811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026